PE-backed life sciences business acquires cancer treatment specialist
A Manchester-based private equity-backed drug development and analytical services company has swooped for an Edinburgh-based cancer treatment and discovery specialist as part of its buy and build strategy.
Concept Life Sciences has acquired Aquila BioMedical, a move it says will bolster its discovery capabilities. The terms of the deal are undisclosed.
Aquila is a pre-clinical contract research organisation with expertise in immuno-oncology, immunology and multiplex histology.
Concept says the business, which was formed in 20... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
